Skip to main content

Educational Network in Ocular Drug Delivery and Therapeutics

Objective

Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big pharma has entered recently. Ocular drug development is a unique field in terms of drug targets and end-points of activity, local drug administration routes, tissue barriers and pharmacokinetics, drug delivery and formulation challenges and local toxicity issues. These issues are slowing down the development of drugs for the unmet needs in ophthalmology. The main objective of the proposal is to educate experts of preclinical ocular R&D to facilitate the success of European pharmaceutical industry and research community. This objective will be reached by joining forces of the leading European academic and industrial researchers in ophthalmology, materials science and nanomedicine, drug delivery and targeting, and systems pharmacology. We shall educate 15 Early Stage Researchers in a network where they will receive tailored, multi-disciplinary and inter-sectoral education in preclinical ocular drug development. The thesis projects are directed to the drug treatment of retinal diseases, the major challenge in the field. The proposal combines new drug candidates from the experts of ophthalmology, innovative drug delivery technologies from pharmaceutical scientists and companies, and modern in vitro, in silico and in vivo methods from various partners. The thesis projects include secondments in academic and industrial partner laboratories and course programme that encompasses the relevant fields in ocular drug development. Therefore, this proposal presents unique combination of innovation and education in the field with obvious need for such education. The ESRs and other outcomes of this project will greatly benefit the future competitiveness of European science and industry in this field of expanding importance.

Call for proposal

H2020-MSCA-ITN-2016
See other projects for this call

Coordinator

ITA-SUOMEN YLIOPISTO
Address
Yliopistonranta 1 E
70211 Kuopio
Finland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 807 436,08

Participants (8)

EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany
EU contribution
€ 373 824,72
Address
Geschwister-scholl-platz
72074 Tuebingen
Activity type
Higher or Secondary Education Establishments
THE QUEEN'S UNIVERSITY OF BELFAST
United Kingdom
EU contribution
€ 546 575,76
Address
University Road Lanyon Building
BT7 1NN Belfast
Activity type
Higher or Secondary Education Establishments
UNIVERSITE DE STRASBOURG
France
EU contribution
€ 262 875,60
Address
Rue Blaise Pascal 4
67081 Strasbourg
Activity type
Higher or Secondary Education Establishments
TECHNISCHE UNIVERSITEIT EINDHOVEN
Netherlands
EU contribution
€ 255 374,28
Address
Groene Loper 3
5612 AE Eindhoven
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI PADOVA
Italy
EU contribution
€ 516 122,64
Address
Via 8 Febbraio 2
35122 Padova
Activity type
Higher or Secondary Education Establishments
UNIVERSITEIT UTRECHT
Netherlands
EU contribution
€ 635 356,32
Address
Heidelberglaan 8
3584 CS Utrecht
Activity type
Higher or Secondary Education Establishments
OZ BIOSCIENCES SAS
France
EU contribution
€ 262 875,60
Address
Parc Scientifique Et Technologique De Luminy Case 922 Bat Ccimp
13288 Marseille
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
CERTARA UK LIMITED
United Kingdom
EU contribution
€ 273 287,88
Address
One London Wall 6Th Floor
EC2Y 5EB London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partners (9)

BAYER AKTIENGESELLSCHAFT
Germany
Address
Kaiser-wilhelm-allee 1
51373 Leverkusen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
20MED THERAPEUTICS BV
Netherlands
Address
Drienerlolaan 5 Kamer Zh252
7522 NB Enschede
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Retina International
Switzerland
Address

Zürich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH
Poland
Address
Ul. Poniatowskiego 15
40 055 Katowice
Activity type
Higher or Secondary Education Establishments
UNIVERSIDAD COMPLUTENSE DE MADRID
Spain
Address
Avenida De Seneca 2
28040 Madrid
Activity type
Higher or Secondary Education Establishments
DELSITECH OY
Finland
Address
Itainen Pitkakatu 4 B
20520 Turku
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Bio-Ker s.r.l
Italy
Address

Gessate
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Vasgen Limited
United Kingdom
Address
1A Strathearn Road
SW19 7LH London
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INNOCORE TECHNOLOGIES BV
Netherlands
Address
L.j. Zielstraweg 1
9713 GX Groningen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)